Recessive dystrophic epidermolysis bullosa (RDEB) is a lifelong genodermatosis
associated with blistering, wounding, and scarring caused by mutations in COL7A1, the …

In orchestrating the wound healing process, the immune system plays a critical role. Hence,
controlling the immune system to repair skin defects is an attractive approach. The highly …

Birch bark extract (Filsuvez®; also known as the developmental name Oleogel-S10), a
topical gel consisting of 10% dry birch bark extract and 90% sunflower oil, is the first therapy …

Abstract We present Dystrophic Epidermolysis Bullosa Cell Therapy (DEBCT), a scalable
platform producing autologous organotypic iPS cell-derived induced skin composite (iSC) …

Background Recessive dystrophic epidermolysis bullosa (RDEB) is a rare, devastating
blistering genodermatosis caused by mutations in the COL7A1 gene, which encodes for …

The ATP-binding cassette superfamily member ABCB5 identifies a subset of skin-resident
mesenchymal stem cells (MSCs) that exhibit potent immunomodulatory and wound healing …

The monogenetic disease epidermolysis bullosa (EB) is characterised by the formation of
extended blisters and lesions on the patient's skin upon minimal mechanical stress. Causal …

Background Epidermolysis bullosa (EB) is a disabling and chronic genodermatosis
characterized by mucocutaneous fragility with blister formation after minimal trauma …

Epidermolysis bullosa (EB) is a devastating genetic skin disease typified by a plethora of
different phenotypes and ranking from severe, early lethal, to mild localized forms. Although …

Recessive dystrophic epidermolysis bullosa (RDEB) is a rare genetic disease resulting from
inadequate type VII collagen (C7). Although recurrent skin blisters and wounds are the most …